OK
The Universal Selection Source:
Plastics & Elastomers
Product News

Solvay Launches Medical-grade Specialty Polymers

Published on 2017-10-30. Author : SpecialChem

Solvay has unveiled a broad portfolio of medical-grade specialty polymers for single-use biopharmaceutical manufacturing applications. Encompassing select grades from five of its most recognized product families, Solvay’s portfolio aims to support the industry’s shift toward single-use peripherals, filtration, bioreactors and containment.

Medical-grade Specialty Polymers

Solvay Specialty Polymers
Solvay Launches Medical-grade Specialty Polymers

In more practical terms, it will help biopharmaceutical manufacturers achieve greater flexibility, faster product development, reduced capital costs and increased speed to market.

The five product families from which Solvay assembled its new biopharmaceutical manufacturing portfolio include:

  • Radel® polyphenylsulfone (PPSU) 
  • Udel® polysulfone (PSU) 
  • AvaSpire® polyaryletherketone (PAEK) 
  • KetaSpire® polyetheretherketone (PEEK) 
  • Ixef® polyarylamide (PARA) 

Gamma Irradiation Compatible Materials


In qualifying materials for single-use applications, Solvay evaluated the effect of gamma irradiation up to 50 kGy on each polymer to ensure it would retain excellent mechanical performance and other application-critical properties.

Results confirmed each material’s compatibility with gamma irradiation, the preferred sterilization method for single-use systems.

All materials are certified under United States Pharmacopeia (USP) Class VI test standards – before and after gamma irradiation – to ensure they meet stringent industry requirements. Solvay is also following industry guidelines to evaluate leachables and extractables for its biopharma portfolio.

PS: If you liked this News, you might enjoy our Plastics & Elastomers Product Newsletter. All the Product News delivered once a week right to your inbox. Sign up here!


Source: Solvay
Dow Far
The 6th Annual Chemicals Sales & Marketing Toolbox
Back to Top